Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- NutraCea Continues to Expand Its International Patent Portfolio
Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655.
- NutraCea Continues to Expand Its International Patent Portfolio
Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655.
- NutraCea Continues to Expand Its International Patent Portfolio
Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655.
- Austrian Court Upholds Novogen Patent for Red Clover Isoflavones
Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld.
- Austrian Court Upholds Novogen Patent for Red Clover Isoflavones
Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld.
- Austrian Court Upholds Novogen Patent for Red Clover Isoflavones
Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology
Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Pagosa Springs, CO – July 14, 2006 – NZyme Pharmaceuticals, Inc. (d/b/a NZyme Pharm) announced today that they have a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease such as heart attacks and ischemic strokes, essential hypertension and deep vein thrombosis.
Subtilisin NAT is a pro-fibrinolytic enzyme that is present in a vegetable cheese-like food called Natto, which is extremely popular in Japan and has been consumed for over 1,000 years. Natto is prepared by fermenting boiled soybeans with Bacillus spp. (e.g., Bacillus subtilis in particular Bacillus subtilis var. natto). Traditionally, Natto was consumed as a folk remedy to treat various conditions and ailments. Subtilisin NAT may be extracted and purified from Natto.
“The new patent will be a timely arrival for the medical community as recent clinical research shows an increasing risk-to-benefit ratio with cardiovascular patients taking aspirin.” said Ralph E. Holsworth, Jr., D.O., co-founder of NZyme Pharm and director of clinical and scientific research. “With over three hundred independent cardiac risk factors, whole blood viscosity has been clinically proven to be the common denominator of vascular disease.”
NZyme brand for oral administration is provided in the form of a softchew and medical bar. All ingredients are 100% organic and non-Genetic Modified Organism (non-GMO). All prescribed medical foods contain 100 mg of Subtilisin NAT which is the fibrinolytic equivalent greater than 2,000 fibrinolytic units (FUs).
About NZyme Pharmaceuticals, Inc.
NZyme Pharmaceuticals, Inc. (NZyme Pharm) has an exclusive license to market enzymes and co-enzymes that have been clinically proven to address the etiology of disease or dysfunction. By going to the cause of the disease process and treating it on a functional basis (such as increased blood viscosity) the disease has a higher incidence of being managed or prevented. The products at NZyme Pharm re-establish fundamental cellular conditions that help people find their way back to health.
# # #
|